SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-038393
Filing Date
2020-08-07
Accepted
2020-08-07 18:37:10
Documents
75
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q acor-10q_20200630.htm   iXBRL 10-Q 2414713
2 EX-31.1 acor-ex311_7.htm EX-31.1 16241
3 EX-31.2 acor-ex312_6.htm EX-31.2 15766
4 EX-32.1 acor-ex321_8.htm EX-32.1 6580
5 EX-32.2 acor-ex322_9.htm EX-32.2 6906
  Complete submission text file 0001564590-20-038393.txt   9756790

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA acor-20200630.xsd EX-101.SCH 58792
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acor-20200630_cal.xml EX-101.CAL 67498
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acor-20200630_def.xml EX-101.DEF 190846
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20200630_lab.xml EX-101.LAB 489676
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20200630_pre.xml EX-101.PRE 368871
11 EXTRACTED XBRL INSTANCE DOCUMENT acor-10q_20200630_htm.xml XML 2080129
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31938 | Film No.: 201085894
SIC: 2836 Biological Products, (No Diagnostic Substances)